socalTECH

APRIL 28, 2014

Thousand Oaks-based wireless hardware provider Xirrus has raised yet another $10M in funding, according to a regulatory filing from the company Monday. Details on the funding have not yet been announced by the company. in the funding round, which so far includes 12 investors.

Thousand Oaks 180

Thousand Oaks Venture Capital Capital Funding 180

socalTECH

DECEMBER 17, 2013

Thousand Oaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease.

Thousand Oaks 180

Thousand Oaks Venture Capital Capital Funding 180

socalTECH

FEBRUARY 21, 2013

Xirrus , the wireless hardware provider based in Thousand Oaks, has just raised $10.1M in a funding round, part of an ongoing $11.0M funding, according to a regulatory filing by the company. Details on the funding have not yet been announced by the company.

Thousand Oaks 164

Thousand Oaks Conference Networking Capital 164

socalTECH

OCTOBER 26, 2009

Thousand Oaks-based Ceres , a developer of energy crops for the biofuels energy, has landed $4,989,144 in a grant from the Department of Energy, as part of a $151M effort to fund energy breakthroughs.

Thousand Oaks 171

Thousand Oaks Research Funding Develop 171

socalTECH

JULY 2, 2010

Thousand Oaks-based Ceres , a developer of biofuel crop technology, has raised another $20M in funding, according to a regulatory filing from the firm Friday. Source of the new funding was not disclosed. The filing indicates the round came from five investors.

Thousand Oaks 150

Thousand Oaks Equity Funding Capital 150

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. According to the company, the funding came from Ally Bridge Group.

Thousand Oaks 164

Thousand Oaks UCLA Venture Capital Equity 164

socalTECH

NOVEMBER 17, 2017

Amgen Ventures , the venture investment arm of Thousand Oaks-based Amgen , is one of the new investors in precision oncology and medicine startup Syapse.

Thousand Oaks 113

Thousand Oaks Funding Software Capital 113

socalTECH

JANUARY 15, 2010

Thousand Oaks-based Amgen said Thursday that it is donating $2M to Haiti relief efforts, as well as encourage its staff to contribute their own funds to organizations aiding in relief and rebuilding efforts in the country.

Thousand Oaks 145

Thousand Oaks Web Organization Sites 145

socalTECH

SEPTEMBER 26, 2012

Thousand Oaks-based Xirrus , the developer of high speed, high performance wireless networking hardware, has raised another big chunk of financing, saying today that it has raised $23.5M in a Series E funding round. Xirrus said the funding will go towards sales growth and its product.

Networking 153

Networking Thousand Oaks Sales Capital 153

socalTECH

MAY 6, 2016

Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio , as an anchor supporter of a new fund. venBio did not say how much Amgen committed to the fund, which is venBio's second life sciences fund. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Help Technology 100

socalTECH

JANUARY 10, 2014

Thousand Oaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M.

Thousand Oaks 147

Thousand Oaks Capital Funding Invest 147

socalTECH

APRIL 29, 2021

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.

Westlake Village 113

Westlake Village Thousand Oaks Funding CalTech 113

socalTECH

JULY 9, 2012

Thousand Oaks-based wireless equipment maker Xirrus appears to have raised $18.4M more in a funding round, part of an ongoing $25.3M funding, according to a regulatory filing by the company. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Funding Capital Company 140

socalTECH

MAY 8, 2012

The venture capital arm of Thousand Oaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M

Thousand Oaks 140

Thousand Oaks Invest Venture Capital Platform 140

socalTECH

MAY 9, 2018

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , is one of the investors in a Boston biotech company, Akili Interactive. Akili is developing digital medicine products aimed at treating cognitive dysfunction, including ADHD, multiple sclerosis, and depression. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Capital 100

socalTECH

AUGUST 31, 2011

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes.

Thousand Oaks 150

Thousand Oaks Venture Capital Capital Funding 150

socalTECH

JULY 2, 2014

San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from Thousand Oaks-based Teledyne , the companies said this morning. Financial terms of the investment were not disclosed. According to Teledyne, the investment also included a strategic partnership deal.

Thousand Oaks 147

Thousand Oaks Invest San Diego Design 147

socalTECH

JULY 8, 2010

Thousand Oaks-based Ceres , a developer of biofuels crop technology, said Thursday that it has completed a private offering of convertible preferred stock. The funding came from Artal Luxembourg, Ambergate Trust, Gimv, and other undisclosed investors. Ceres is developing improved seed varieties--including. READ MORE>>.

Thousand Oaks 140

Thousand Oaks Venture Capital Design Activity 140

socalTECH

MARCH 8, 2016

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Lightstone Ventures also participated in the funding. Tizona is based in South San Francisco, and is developing treatments for cancer and autoimmune diseases. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Invest 100

socalTECH

JANUARY 3, 2013

YouMail is led by Alex Quilici, and backed by VantagePoint Capital Partners, the Tech Coast Angels, the Tech Coast Angels ACE Fund, Siemer Ventures, and the CrunchFund. Red Pocket Mobile is based in Thousand Oaks. The two said that Red Pocket Mobile's customers can now access YouMail from any compatible GSM phone.

Tech Coast Angels 138

Tech Coast Angels Thousand Oaks Mobile Services 138

socalTECH

MAY 20, 2010

The firm, which is headed by Zorik Gordon, was venture backed by VantagePoint Venture Partners, Rho Ventures, Galleon Group, European Founders Fund, and others. The firm sold 4,166,667 shares of stock at $13.00 per share, after pricing below its initial offering range on Wednesday evening, and had traded as high as $15.26 during the day.

ReachLocal 157

ReachLocal Woodland Hills Thousand Oaks NewEgg 157

socalTECH

APRIL 8, 2014

Thousand Oaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer. READ MORE>>. atara biotherapeutics renal disease lifescience amgen executive board'

Thousand Oaks 138

Thousand Oaks Invest Capital Funding 138

socalTECH

DECEMBER 27, 2019

Whats happening in regions in our counties with startup and entrepreneurial activity, especially in the Conejo Valley (Calabasas to Thousand Oaks) is exciting. Many jobs have been created and companies have received funding through our efforts of supporting and bringing value to founders.

Startup 196

Startup Thousand Oaks Mentor Ventura 196

socalTECH

JUNE 17, 2010

Inphi--which lists its headquarters as Sunnyvale, but has most of its operations in Westlake Village and Thousand Oaks--is looking to list on the NYSE and IPHI. Inphi is venture backed by Walden International, Tallwood, Mayfield Fund, and Samsung Electronics. In its S-1, the firm said it had net income of $7.3M

Westlake Village 133

Westlake Village Thousand Oaks Southern California .Net 133

socalTECH

APRIL 20, 2017

Thousand Oaks-based wireless networking equipment maker Xirrus has been acquired by Riverbed , to help bolster its SD WAN efforts, the two said on Wednesday. Financial terms of the acquisition were not announced. Riverbed said it will continue to offer up Xirrus as a stand-alone enterprise WLAN solution.

Thousand Oaks 127

Thousand Oaks Acquisition Startup Networking 127

socalTECH

JANUARY 22, 2010

Among the biggest investments in the region in the quarter were Torrance-based Amonix , which received nearly $40M in funding; among other large deals were San Diego's Zogenix with $35M raised, and Thousand Oaks-based Xirrus , with $20.1M. Orange County saw $48.7M in investments for the quarter.

Southern California 154

Southern California Venture Capital Invest Orange County 154

socalTECH

JANUARY 9, 2017

Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

JANUARY 7, 2016

Thousand Oaks-based biotech giant Amgen is the a new investor in a round for Alector , a developer of immuno-modulatory therapies for Alzheimer's disease and other neurogenerative disorders, which announced a $29.5M funding today. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Google Research Funding 100

socalTECH

OCTOBER 31, 2017

Thousand Oaks-based biotech giant a href="[link] said on Monday that it has agreed to acquire its joint venture with Kirin, Kirin-Amgen , in a deal worth $780M. The JV was created in 1984 as a 50-50 joint venture to fund global development of Amgen's EPOGEN, and later included the company's other pharmaceutical products.

Thousand Oaks 113

Thousand Oaks Startup Funding Help 113

socalTECH

JULY 25, 2018

South San Francisco-based Alector , a biotechnology company focused on finding treatments for neurodegenerative diseases and cancer, announced Wednesday that it has raised $133M in a Series E funding round. Alector said the financing will go to advance its clinical programs and expand the company's discovery platform. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Capital Platform Funding 100

socalTECH

JULY 30, 2018

Thousand Oaks-based Amgen has returned as one of the investors in cancer therapeutis developer Sutro Biopharma , as part of an $85.4M funding round. in a Series E funding round. South San Francisco-based Sutro Biopharma said last week that it has raised $85.4M

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

OCTOBER 22, 2015

Thousand Oaks-based Amgen , via its nonprofit arm, The Amgen Foundation , said Wednesday that it will spend more than $4M to help bring hands on biotechnology labs to schools.

Thousand Oaks 100

Thousand Oaks Funding Invest Help 100

SoCal Tech Calendar

DECEMBER 3, 2018

He will talk about some of the noteworthy funding deals, acquisitions, exits and trends of 2018, and talk about what might be in store for the future. Lundring Events Center, California Lutheran University, 130 Overton Court (inside Gilbert Sports and Fitness Center), Thousand Oaks. Wednesday, December 5, 6 - 8 p.m.,

Thousand Oaks 100

Thousand Oaks Startup Acquisition Funding 100

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. In addition to Amgen, Adheron has received venture capital from Health Care Ventures, MedImmune Ventures, Partners Innovation Fund, and SROne.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

OCTOBER 12, 2016

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M As part of the funding, F-Prime's Thomas Beck and Ben Auspitz have joined the company's board. in a Series A investment. The investment came from F-Prime Capital Partners.

Thousand Oaks 100

Thousand Oaks Research Activity Invest 100

socalTECH

DECEMBER 8, 2022

Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases.

Westlake Village 100

Westlake Village Thousand Oaks CalTech Funding 100

socalTECH

DECEMBER 11, 2017

Thousand Oaks-based biotech giant Amgen said this morning that it is donating $500,000 to relief efforts for the Southern California wildfires. The funds come from Amgen's nonprofit arm, the Amgen Foundation. Amgen normally does a 1:1 match to employee contributions to qualified nonprofits.

Thousand Oaks 100

Thousand Oaks Southern California Ventura Funding 100